(Q67491834)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320909%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

Immunocytochemistry and in situ hybridisation of epidermal growth factor receptor and relation to prognostic factors in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320909%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

6 December 2023

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

6 December 2023

author name string

M. Bilous

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1320909

13 September 2022

J. Milliken

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1320909

13 September 2022

J. M. Mathijs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1320909

13 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1320909

13 September 2022

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320909%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

14 September 2019

https://api.elsevier.com/content/article/PII:095980499290449C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

https://api.elsevier.com/content/article/PII:095980499290449C?httpAccept=text/plain

6 December 2023

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

European Journal of Cancer

6 December 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320909%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

28A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320909%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

1033-1037

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320909%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

6-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320909%20AND%20SRC:MED&resulttype=core&format=json

Response to tamoxifen in estrogen receptor-poor metastatic breast cancer

14 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

6 December 2023

Epidermal Growth Factor

2

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breast

6 December 2023

3

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Immunohistochemical studies on oncogene products (c-erbB-2, EGFR, c-myc) and estrogen receptor in benign and malignant breast lesions. With special reference to their prognostic significance in carcinoma

6 December 2023

4

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Localization of immunoreactive epidermal growth factor receptors in human nervous system.

6 December 2023

5

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

6 December 2023

6

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup

6 December 2023

7

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Prognostic value of epidermal growth factor receptor in node-positive breast cancer

6 December 2023

8

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy

6 December 2023

9

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

6 December 2023

10

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques.

6 December 2023

11

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Whither cytosolic estrogen receptor assays? A comparison of commercially available kits for estrogen receptor assay

6 December 2023

12

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

6 December 2023

13

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Expression of epidermal growth factor receptor in breast carcinoma

6 December 2023

14

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Immunocytochemical determination of epidermal growth factor receptor with monoclonal EGFR1 antibody in primary breast cancer patients

6 December 2023

15

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: relationship to estrogen receptor and lymphatic invasion

6 December 2023

16

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Epidermal growth factor receptors in human breast and endometrial carcinomas

6 December 2023

18

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancer

6 December 2023

19

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure

6 December 2023

20

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays

6 December 2023

23

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

6 December 2023

24

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit

6 December 2023

25

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer

6 December 2023

26

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neu

6 December 2023

27

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.

6 December 2023

29

1 reference

https://api.crossref.org/works/10.1016/0959-8049(92)90449-C

6 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1320909%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference